The number of people with susceptibility test result for rifampicin in Hungary
Hungary: The number of people with susceptibility test result for rifampicin was 142 in 2021. ▼ Falling
Latest (2021)
142
Change on year
down 9.0%
World rank
103rd
of 155 countries
All-time high
302
in 2018
All-time low
142
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Hungary, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Hungary stood at 142. That is the lowest value across all 5 years on record.
Compared with earlier readings it is down 9.0% on the previous year and down 50.5% over five years.
Hungary ranks 103rd of 155 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Hungary, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 287 | — |
| 2018 | 302 | +5.2% |
| 2019 | 243 | -19.5% |
| 2020 | 156 | -35.8% |
| 2021 | 142 | -9.0% |
Hungary compared with similar countries
- Hungary's 142 is above the median for high income countries, which is 142, 1.0× the median. (61 countries reporting)
- Hungary's 142 is below the median for Europe & Central Asia, which is 229.5, 62% of the median. (44 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 277.33 | 243 | 302 | 3 |
| 2020s | 149 | 142 | 156 | 2 |
Countries ranked near Hungary
More health data for Hungary
- Un projection of annual infant deaths, annual growth rate -2.63 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.5277 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,225 deaths per 1,000 people (2090)
- Number of infants who die before age 1 37 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.27 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0224 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.2 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Hungary?
- The number of people with susceptibility test result for rifampicin in Hungary was 142 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Hungary?
- The highest recorded value was 302 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Hungary?
- The lowest recorded value was 142 in 2021.
- How does Hungary rank for the number of people with susceptibility test result for rifampicin?
- Hungary ranks 103rd out of 155 countries with data for 2021.
- Where does this Hungary data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).